<?xml version="1.0" encoding="UTF-8"?>
<p>The widespread clinical use of dsRNA based preparations is often hampered by their instability in biological media, a high level of effective doses and side effects. Numerous efforts are undertaken to improve dsRNA efficiency; particular attention is paid to drug formulation that can enhance the action of the main substance or reduce side effects; preparations on polymeric carriers and the means of targeted delivery [
 <xref ref-type="bibr" rid="CR79">79</xref>â€“
 <xref ref-type="bibr" rid="CR81">81</xref>].
</p>
